Kevin D. Freeman - 17 Jul 2025 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director
Signature
Jack W. Callicutt, by power of attorney
Issuer symbol
GALT
Transactions as of
17 Jul 2025
Net transactions value
+$14,495
Form type
4
Filing time
18 Jul 2025, 10:38:28 UTC
Previous filing
27 Jan 2025
Next filing
23 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FREEMAN KEVIN D Director C/O GALECTIN THERAPEUTICS INC., 4960 PEACHTREE INDUSTRIAL BLVD., STE 240, NORCROSS Jack W. Callicutt, by power of attorney 18 Jul 2025 0001522478

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Purchase $14,495 +5,000 +11% $2.90 49,769 17 Jul 2025 Direct
holding GALT Common Stock 80,000 17 Jul 2025 By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC F1
holding GALT Common Stock 18,063 17 Jul 2025 IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.